美国的一项小型试验发现,在对脊柱脊椎进行胎儿外科手术期间,胎盘衍生干细胞是安全的,并且改善了运动功能和6个婴儿的大脑异常。 A small U.S. trial found placenta-derived stem cells given during fetal surgery for spina bifida were safe and improved motor function and brain abnormalities in six infants.

一个小型的美国试验发现,在对脊椎脊柱进行胎儿外科手术时,采用胎盘衍生干细胞是安全的,并可能改善结果。 A small U.S. trial found that applying placenta-derived stem cells during fetal surgery for spina bifida is safe and may improve outcomes. 6个有病的胎儿在24至25周的时间里接受了干细胞,同时进行了标准的子宫内修复。 Six fetuses with the condition received stem cells alongside standard in-utero repair at 24–25 weeks. 婴儿出生后,没有出现并发症,运动功能得到改善,在严重情况下脑畸形出现逆转。 After birth, infants showed no complications, improved motor function, and reversal of brain abnormalities seen in severe cases. 研究人员说,治疗可能有助于修复神经损伤,但还需要进行更大的试验,以确认长期效益和有效性。 Researchers say the therapy may help repair nerve damage, but larger trials are needed to confirm long-term benefits and effectiveness.